Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Medical Oncology
Upper Tract Urothelial Cancer
Questions discussed in this category
Do people extrapolate data from the NIAGARA trial regarding peri-operative durvalumab cisplatin based chemo to upper tract urothelial carcinoma?
2 Answers available
22502
Papers discussed in this category
Lancet, 2020 Mar 05
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial.
J Clin Oncol, 2023 Mar 10
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.
The New England journal of medicine, 2024 Sep 15
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.
The New England journal of medicine, 2024 Mar 07
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
Related Topics in Medical Oncology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Oncology
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers